The Aurora kinases comprise a family of evolutionary conserved serine/threonine kinases (Aurora-A, Aurora-B, and Aurora-C).Aurora kinases regulate a variety of cell cycle-related processes and are necessary for the assembly and operation of the bipolar spindle during the mitotic and meiotic phases.
While Aurora-A, Aurora-B, and Aurora-C have very similar subcellular localizations and functions during mitosis, they also share a highly conserved kinase domain. While Aurora-B and Aurora-C are necessary for condensation, attachment to kinetochores, and alignment of chromosomes during (pro-)metaphase and cytokinesis, Aurora-A primarily regulates centrosome maturation and bipolar spindle assembly. All Aurora kinase members play oncogenic roles related to their mitotic activity and support the survival and growth of cancer cells in human tumors. Researchers studying cancer have become interested in inhibitors that target Aurora kinases.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V94934 | Cenisertib benzoate | 1145859-64-8 | Cenisertib (AS-703569) benzoate is an ATP-competitive multikinase inhibitor that inhibits the activities of Aurora-kinase-A/B, ABL1, AKT, STAT5, and FLT3. |
![]() |
V88589 | DBPR728 | 2702965-64-6 | DBPR728 is an acyl prodrug of 6K465 that carries fewer hydrogen bond donors. |
![]() |
V104462 | FAK-IN-22 | 2703920-02-7 | FAK-IN-22 (Compound 26) is an inhibitor of FAK, JAK3, and Aurora B with IC50 values of 50.94 nM, 9.99 nM, and 0.49 nM, respectively, and can effectively inhibit the tumorigenesis and metastasis of pancreatic ductal adenocarcinoma (PDAC). |
![]() |
V84552 | FAK/aurora kinase-IN-1 | 2178117-69-4 | |
![]() |
V103749 | GW814408X | 886599-05-9 | GW814408X is a kinase chemical genetic group (KCGS) compound that inhibits AURKC kinases involved in cell cycle progression, checkpoint regulation, and cell division. |
![]() |
V51923 | JB170 | 2705844-82-0 | JB170 is a potent and specific PROTAC-mediated degrader of AURORA-A (DC50=28 nM) formed by linking Alisertib to the Cereblon ligand Thalidomide. |
![]() |
V94222 | MLN8054 sodium | 869366-15-4 | MLN8054 sodium is an Aurora A inhibitor with radiosensitizing effects. |
![]() |
V4347 | Phthalazinone pyrazole | 880487-62-7 | Phthalazinone pyrazole is a potent, selective, orally bioactive Aurora-Kinase inhibitor (antagonist) with IC50 of 0.031 μM. |
![]() |
V94063 | PROTAC MPS1 degrader 1 | PROTAC MPS1 degrader 1 (compound 19) is a potent degrader of monopolar spindle 1 (Mps1, TTK), AURKA, and AURKB with DC50 of 17.7, 108.7, and 570.3 nM, respectively. | |
![]() |
V94065 | PROTAC MPS1 degrader 2 | PROTAC MPS1 degrader 2 (compound 15) is a potent degrader of monopolar spindle 1 (Mps1, TTK), AURKA, and AURKB with DC50 of 42.0, 2.1, and 154.0 nM, respectively. | |
![]() |
V4666 | SCH-1473759 | 1094069-99-4 | SCH-1473759 (SCH1473759) is a novel, potent and selective aurora inhibitor with anticancer effects. |
![]() |
V35264 | SP-96 | 2682114-54-9 | SP-96 is a specific and ATP-competitive Aurora B inhibitor (antagonist) with IC50 of 0.316 nM and >2000-fold selectivity for FLT3 and KIT. |
![]() |
V88593 | TAK-901 hydrochloride | 934542-50-4 | TAK-901 hydrochloride is a multi-target aurora kinase inhibitor with IC50 values of 21 and 15 nM for aurora kinase A and B, respectively. |
![]() |
V55050 | Tenacienin B | 80508-42-5 | Tenacigenin B is a steroid extracted from Alocasia. |
![]() |
V55051 | Tinengotinib (TT 00420) | 2230490-29-4 | Tinengotinib is a modulator of one or more protein kinases, such as Aurora kinase and VEGFR kinase. |
![]() |
V35166 | Tripolin A ((E)-Tripolin A) | 1148118-92-6 | Tripolin A ((E)-Tripolin A) is a specific, non-ATP competitive Aurora A kinase inhibitor (antagonist) with IC50s of 1.5 μM and 7 μM for Aurora A and Aurora B, respectively. |
![]() |
V88596 | Tripolin B | 186611-44-9 | Tripolin B is an ATP-competitive Aurora kinase inhibitor with IC50 values of 2.5 µM and 6 µM for Aurora A and Aurora B kinases, respectively. |
![]() |
V98046 | TY-011 | 1389439-77-3 | TY-011 is an Aurora A/B kinase inhibitor. |
![]() |
V73175 | YM-08 | 812647-88-4 | YM-08 (Compounds 7a) is an inhibitor (blocker/antagonist) of SIRT2 that can penetrate the BBB (blood-brain barrier), with IC50 of 19.9 μM. |
![]() |
V4411 | Ilorasertib | 1227939-82-3 | Ilorasertib (also known as ABT-348) is a potent, novel, orally bioavailable and ATP-competitive multi-kinase inhibitor withIC50s for inhibiting binding Aurora B (7 nM), C (1 nM), and A (120 nM), and also inhibits RET tyrosine kinase, PDGFRβ, and Flt1 withIC50s of 7 nM, 3 nM and 32 nM. |